132: Research Strategies of Memphis — Memphis, Tennessee

132: Research Strategies of Memphis is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

132: Research Strategies of Memphis has participated in 1 clinical trials.

Therapeutic areas: Attention Deficit Hyperactivity Disorder.

Sponsors: Arbor Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 132: Research Strategies of Memphis?

132: Research Strategies of Memphis has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 132: Research Strategies of Memphis conducted?

132: Research Strategies of Memphis has 1 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder.

Is 132: Research Strategies of Memphis accredited by Crixeo Health?

132: Research Strategies of Memphis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 132: Research Strategies of Memphis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.